The clinical role of glutamine supplementation in patients with multiple trauma: A narrative review

Anaesthesia and Intensive Care

Volumn 41, Issue 1, 2013, Pages 24-34

  Al Balushi, R M ^a   Cohen, J ^a,b   Banks, M ^a,b   Paratz, J D ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Alanyl glutamine; Enteral; Glutamine; Head injury; Intravenous; Parenteral; Supplementation; Trauma

Indexed keywords

ALANYLGLUTAMINE; FC RECEPTOR; GLUTAMINE; HLA DR ANTIGEN;

AMINO ACID METABOLISM; BACTERIAL TRANSLOCATION; BLEEDING; BOLUS INJECTION; CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; ENTERIC FEEDING; HUMAN; IMMUNE RESPONSE; INFECTIOUS COMPLICATION; INSULIN RESISTANCE; META ANALYSIS (TOPIC); MORTALITY; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PRACTICE GUIDELINE; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; STRESS ULCER; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TOTAL PARENTERAL NUTRITION; TRAUMATIC BRAIN INJURY; CLINICAL TRIAL (TOPIC); METHODOLOGY; NUTRITIONAL REQUIREMENT; PARENTERAL NUTRITION; PATHOPHYSIOLOGY;

CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; GLUTAMINE; HUMANS; MULTIPLE TRAUMA; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION;

MLCS; MLOWN;

EID: 84874426090     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1304100106     Document Type: Review

References (87)

1. Napolitano LM, Faist E, Wichmann MW, Coimbra R. Immune dysfunction in trauma. Surg Clin North Am 1999; 79:1385- 1416.
2. O 'Mahony JB, Palder SB, Wood JJ, McIrvine A, Rodrick ML, Demling RH et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24:869-875.
3. Faist E, Mewes A, Strasser T, Walz A, Alkan S, Baker C et al. Alteration of monocyte function following major injury. Arch Surg 1988; 123:287-292.
4. Ditschkowski M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 1999; 229:246-254.
5. Baker CC, Oppenheimer L, Stephens B, Lewis FR, Trunkey DD. Epidemiology of trauma deaths. Am J Surg 1980; 140:144- 150.
6. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302:2323-2329.
7. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med 2002; 30:2022-2029.
8. Avenell A. Glutamine in critical care: Current evidence from systematic reviews. Proc Nutr Soc 2006; 65:236-241.
9. García-de-Lorenzo A, Zarazaga A, García-Luna PP, Gonzalez- Huix F, López-Martínez J, Miján A et al. Clinical evidence for enteral nutritional support with glutamine: A systematic review. Nutrition 2003; 19:805-811.
10. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24:1125-1128.
11. Moore FA, Sauaia A, Moore EE, Haenel JB, Burch JM, Lezotte DC. Postinjury multiple organ failure: A bimodal phenomenon. J Trauma 1996; 40:501-510.
12. Hoch RC, Rodriguez R, Manning T, Bishop M, Mead P, Shoemaker WC et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21:839-845.
13. Buckingham JC. Hypothalamo-pituitary responses to trauma. Br Med Bull 1985; 41:203-211.
14. Monk DN, Plank LD, Franch-Arcas G, Finn PJ, Streat SJ, Hill GL. Sequential changes in the metabolic response in critically injured patients during the first 25 days after blunt trauma. Ann Surg 1996; 223:395-405.
15. Black PR, Brooks DC, Bessey PQ, Wolfe RR, Wilmore DW. Mechanisms of insulin resistance following injury. Ann Surg 1982; 196:420-435.
16. K lein S, Peters EJ, Shangraw RE, Wolfe RR. Lipolytic response to metabolic stress in critically ill patients. Crit Care Med 1991; 19:776-779.
17. Gamrin L, Andersson K, Hultman E, Nilsson E, Essén P, Wernerman J. Longitudinal changes of biochemical parameters in muscle during critical illness. Metabolism 1997; 46:756- 762.
18. Finn PJ, Plank LD, Clark MA, Connolly AB, Hill GL. Progressive cellular dehydration and proteolysis in critically ill patients. Lancet 1996; 347:654-656.
19. Wolfe RR, Goodenough RD, Burke JF, Wolfe MH. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 1983; 197:163-171.
20. Streat SJ, Beddoe AH, Hill GL. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma 1987; 27:262-266.
21. Petersson B, Vinnars E, Waller SO, Wernerman J. Long-term changes in muscle free amino acid levels after elective abdominal surgery. Br J Surg 1992; 79:212-216.
22. Jackson NC, Carroll PV, Russell-Jones DL, Sönksen PH, Treacher DF, Umpleby AM. The metabolic consequences of critical illness: Acute effects on glutamine and protein metabolism. Am J Physiol 1999; 276:E163-170.
23. Newsholme P. Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 2001; 131:2515S-2522S.
24. Boelens PG, Houdijk AP, Fonk JC, Nijveldt RJ, Ferwerda CC, Von Blomberg-Van Der Flier BM et al. Glutamine-enriched enteral nutrition increases HLA-DR expression on monocytes of trauma patients. J Nutr 2002; 132:2580-2586.
25. Jungas RL, Halperin ML, Brosnan JT. Quantitative analysis of amino acid oxidation and related gluconeogenesis in humans. Physiol Rev 1992; 72:419-448.
26. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J. Human kidney and liver gluconeogenesis: Evidence for organ substrate selectivity. Am J Physiol 1998; 274:E817-826.
27. Gstraunthaler G, Holcomb T, Feifel E, Liu W, Spitaler N, Curthoys NP. Differential expression and acid-base regulation of glutaminase mRNAs in gluconeogenic LLC-PK(1)-FBPase (+) cells. Am J Physiol Renal Physiol 2000; 278:F227-237.
28. McCauley R, Kong SE, Hall J. Glutamine and nucleotide metabolism within enterocytes. JPEN J Parenter Enteral Nutr 1998; 22:105-111.
29. Houdijk AP, van Leeuwen PA, Teerlink T, Flinkerbusch EL, Boermeester MA, Sauerwein HP et al. Glutamine-enriched enteral diet increases renal arginine production. JPEN J Parenter Enteral Nutr 1994; 18:422-426.
30. Melis GC, Boelens PG, van der Sijp JR, Popovici T, De Bandt JP, Cynober L et al. The feeding route (enteral or parenteral) affects the plasma response of the dipetide Ala-Gln and the amino acids glutamine, citrulline and arginine, with the administration of Ala-Gln in preoperative patients. Br J Nutr 2005; 94:19-26.
31. Fläring UB, Rooyackers OE, Wernerman J, Hammarqvist F. Glutamine attenuates post-traumatic glutathione depletion in human muscle. Clin Sci 2003; 104:275-282.
32. Bakalar B, Duska F, Pachl J, Fric M, Otahal M, Pazout J et al. Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients. Crit Care Med 2006; 34:381-386.
33. Grau T, Bonet A, Minambres E, Pineiro L, Irles JA, Robles A et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011; 39:1263-1268.
34. Z hang Z, Qin HD, Ni HB, Xu Y, Wu HR, Cheng H et al. Effect of early enriched parenteral alanyl-glutamine on heat shock protein 70 (HSP70) expression in critical patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2007; 19:481-484.
35. Singleton KD, Serkova N, Beckey VE, Wischmeyer PE. Glutamine attenuates lung injury and improves survival after sepsis: Role of enhanced heat shock protein expression. Crit Care Med 2005; 33:1206-1213.
36. Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez- Estivariz C, Griffith DP et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients. Intensive Care Med 2005; 31:1079-1086.
37. De-Souza DA, Greene LJ. Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine. Crit Care Med 2005; 33:1125-1135.
38. Chun H, Sasaki M, Fujiyama Y, Bamba T. Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J Gastroenterol 1997; 32:189-195.
39. Gianotti L, Alexander JW, Gennari R, Pyles T, Babcock GF. Oral glutamine decreases bacterial translocation and improves survival in experimental gut-origin sepsis. JPEN J Parenter Enteral Nutr 1995; 19:69-74.
40. Conejero R, Bonet A, Grau T, Esteban A, Mesejo A, Montejo JC et al. Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: A randomized, single-blind, prospective, multicenter study. Nutrition 2002; 18:716-721.
41. Z hou YP, Jiang ZM, Sun YH, He GZ, Shu H. The effects of supplemental glutamine dipeptide on gut integrity and clinical outcome after major escharectomy in severe burns: A randomized, double-blind, controlled clinical trial. Clin Nutr Suppl 2004; 1:55-60.
42. Velasco N, Hernandez G, Wainstein C, Castillo L, Maiz A, Lopez F. Influence of polymeric enteral nutrition supplemented with different doses of glutamine on gut permeability in critically ill patients. Nutrition 2001; 17:907-911.
43. Gamrin L, Essén P, Forsberg AM, Hultman E, Wernerman J. A descriptive study of skeletal muscle metabolism in critically ill patients: Free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med 1996; 24:575-583.
44. Mittendorfer B, Gore DC, Herndon DN, Wolfe RR. Accelerated glutamine synthesis in critically ill patients cannot maintain normal intramuscular free glutamine concentration. JPEN J Parenter Enteral Nutr 1999; 23:243-250.
45. Parry-Billings M, Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA. Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 1992; 127:1237-1240.
46. Parry-Billings M, Evans J, Calder PC, Newsholme EA. Does glutamine contribute to immunosuppression after major burns? Lancet 1990; 336:523-525.
47. Gore DC, Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg 1994; 129:1318-1323.
48. Askanazi J, Carpentier YA, Michelsen CB, Elwyn DH, Furst P, Kantrowitz LR. Muscle and plasma amino acids following injury. Influence of intercurrent infection. Ann Surg 1980; 192:78-85.
49. Weingartmann G, Oehler R, Derkits S, Oismüller C, Függer R, Roth E. HSP70 expression in granulocytes and lymphocytes of patients with polytrauma: Comparison with plasma glutamine. Clin Nutr 1999; 18:121-124.
50. Lacey JM, Wilmore DW. Is glutamine a conditionally essential amino acid? Nutr Rev 1990; 48:297-309.
51. Moore FA, Moore EE, Jones TN, McCroskey BL, Peterson VM. TEN versus TPN following major abdominal traumareduced septic morbidity. J Trauma 1989; 29:916-922.
52. Taylor SJ, Fettes SB, Jewkes C, Nelson RJ. Prospective, randomized, controlled trial to determine the effect of early enhanced enteral nutrition on clinical outcome in mechanically ventilated patients suffering head injury. Crit Care Med 1999; 27:2525-2531.
53. Moore EE, Jones TN. Benefits of immediate jejunostomy feeding after major abdominal trauma - A prospective, randomized study. J Trauma 1986; 26:874-881.
54. Grahm TW, Zadrozny DB, Harrington T. The benefits of early jejunal hyperalimentation in the head-injured patient. Neurosurgery 1989; 25:729-735.
55. Doig GS, Heighes PT, Simpson F, Sweetman EA, Davies AR. Early enteral nutrition, provided within 24 h of injury or intensive care unit admission, significantly reduces mortality in critically ill patients: A meta-analysis of randomised controlled trials. Intensive Care Med 2009; 35:2018-2027.
56. K udsk KA, Croce MA, Fabian TC, Minard G, Tolley EA, Poret HA et al. Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma. Ann Surg 1992; 215:503-511.
57. Soguel L, Chioléro RL, Ruffieux C, Berger MM. Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients. Nutrition 2008; 24:1123-1132.
58. Matthews DE, Marano MA, Campbell RG. Splanchnic bed utilization of glutamine and glutamic acid in humans. Am J Physiol 1993; 264:E848-854.
59. Haisch M, Fukagawa NK, Matthews DE. Oxidation of glutamine by the splanchnic bed in humans. Am J Physiol Endocrinol Metab 2000; 278:E593-602.
60. Déchelotte P, Darmaun D, Rongier M, Hecketsweiler B, Rigal O, Desjeux JF. Absorption and metabolic effects of enterally administered glutamine in humans. Am J Physiol 1991; 260:G677-682.
61. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition 1999; 15:108-115.
62. Luo M, Bazargan N, Griffith DP, Estívariz CF, Leader LM, Easley KA et al. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: A pilot study. Clin Nutr 2008; 27:297-306.
63. Long CL, Nelson KM, DiRienzo DB, Weis JK, Stahl RD, Broussard TD et al. Glutamine supplementation of enteral nutrition: Impact on whole body protein kinetics and glucose metabolism in critically ill patients. JPEN J Parenter Enteral Nutr 1995; 19:470-476.
64. Long CL, Borghesi L, Stahl R, Clark JA, Geiger JW, DiRienzo DB et al. Impact of enteral feeding of a glutamine-supplemented formula on the hypoaminoacidemic response in trauma patients. J Trauma 1996; 40:97-102.
65. Houdijk AP, Rijnsburger ER, Jansen J, Wesdorp RI, Weiss JK, McCamish MA et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 1998; 352:772-776.
66. Schulman AS, Willcutts KF, Claridge JA, Evans HL, Radigan AE, O'Donnell KB et al. Does the addition of glutamine to enteral feeds affect patient mortality? Crit Care Med 2005; 33:2501-2506.
67. K ajikawa H, Mitsumori M, Ohmomo S. Stimulatory and inhibitory effects of protein amino acids on growth rate and efficiency of mixed ruminal bacteria. J Dairy Sci 2002; 85:2015-2022.
68. Schulman AS, Willcutts KF, Claridge JA, O'Donnell KB, Radigan AE, Evans HL et al. Does enteral glutamine supplementation decrease infectious morbidity? Surg Infect 2006; 7:29-35.
69. Houdijk AP, Nijveldt RJ, van Leeuwen PA. Glutamineenriched enteral feeding in trauma patients: Reduced infectious morbidity is not related to changes in endocrine and metabolic responses. JPEN J Parenter Enteral Nutr 1999; 23:S52-58.
70. Hershman MJ, Cheadle WG, Wellhausen SR, Davidson PF, Polk HC Jr. Monocyte HLA-DR antigen expression characterizes clinical outcome in the trauma patient. Br J Surg 1990; 77:204-207.
71. McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN J Parenter Enteral Nutr 2008; 32:28-35.
72. Y ang DL, Xu JF. Effect of dipeptide of glutamine and alanine on severe traumatic brain injury. Chin J Traumatol 2007; 10:145-149.
73. Schirmer CM, Kornbluth J, Heilman CB, Bhardwaj A. Gastrointestinal prophylaxis in neurocritical care. Neurocrit Care 2012; 16:184-193.
74. Eroglu A. The effect of intravenous alanyl-glutamine supplementation on plasma glutathione levels in intensive care unit trauma patients receiving enteral nutrition: The results of a randomized controlled trial. Anesth Analg 2009; 109:502-505.
75. Pérez-Bárcena J, Crespí C, Regueiro V, Marsé P, Raurich JM, Ibáñez J et al. Lack of effect of glutamine administration to boost the innate immune system response in trauma patients in the intensive care unit. Crit Care 2010; 14:R233.
76. Doig GS, Simpson F, Delaney A. A review of the true methodological quality of nutritional support trials conducted in the critically ill: Time for improvement. Anesth Analg 2005; 100:527-533.
77. Doig GS, Simpson F, Sweetman EA. Evidence-based nutrition support in the intensive care unit: An update on reported trial quality. Curr Opin Clin Nutr Metab Care 2009; 12:201- 206.
78. Heyland DK, Dhaliwal R, Day AG, Muscedere J, Drover J, Suchner U et al. Reducing deaths due to oxidative stress (the REDOXS study): Rationale and study design for a randomized trial of glutamine and antioxidant supplementation in criticallyill patients. Proc Nutr Soc 2006; 65:250-263.
79. Wernerman J, Kirketeig T, Andersson B, Berthelson H, Ersson A, Friberg H et al. Scandinavian glutamine trial: A pragmatic multi-centre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 2011; 55:812-818.
80. Wernerman J. Glutamine and acute illness. Curr Opin Crit Care 2003; 9:279-285.
81. Beale RJ, Sherry T, Lei K, Campbell-Stephen L, McCook J, Smith J et al. Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: Outcome of a randomized, controlled, double-blind trial. Crit Care Med 2008; 36:131-144.
82. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: A randomized study in trauma patients. JPEN J Parenter Enteral Nutr 2007; 31:119-126.
83. Brantley S, Pierce J. Effects of enteral glutamine on trauma patients. Nutr Clin Pract 2000; 15:S13.
84. Macfie J. European round table: The use of immunonutrients in the critically ill. Clin Nutr 2004; 23:1426-1429.
85. Jones NE, Heyland DK. Pharmaconutrition: A new emerging paradigm. Curr Opin Gastroenterol 2008; 24:215-222.
86. Dupertuis YM, Meguid MM, Pichard C. Advancing from immunonutrition to a pharmaconutrition: A gigantic challenge. Curr Opin Clin Nutr Metab Care 2009; 12:398-403.
87. Ochoa JB. Separating pharmaconutrition from classic nutrition goals: A necessary step. Crit Care Med 2008; 36:347-348.